Jennifer Rumsey
Known title: DirectorCIK: 0001651631
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cummins Featured in Zacks Investment Ideas Highlight. Cummins was recently featured in a Zacks Investment Ideas segment alongside Argenx and PACCAR, bringing renewed analytical attention to the company's position in the industrial sector. This coverage coincides with broader market discussions around non-AI stocks that may offer value during technology-driven market rotations. The focus highlights ongoing interest in established industrial manufacturers as market participants evaluate sector-specific opportunities.
Transaction History
| MMM | ▲ Buy | Grant | 1,196 | $183K | 6/5/2026 | View on chart |
| CMI | ▲ Buy | Grant | 44,736 | $0 | 3/1/2026 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 19,450 | $11.4M | 3/1/2026 | View on chart |
| CMI | ▼ Sell | Gift | 4,165 | $0 | 11/13/2025 | View on chart |
| CMI | ▲ Buy | Option Exercise | 4,570 | $499K | 11/11/2025 | View on chart |
| CMI | ▼ Sell | Open Market | 2,880 | $1.4M | 11/11/2025 | View on chart |
| CMI | ▼ Sell | Open Market | 1,690 | $802K | 11/11/2025 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 5,590 | $2.1M | 3/1/2025 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 9,244 | $3.4M | 3/1/2025 | View on chart |
| CMI | ▲ Buy | Grant | 21,885 | $0 | 3/1/2025 | View on chart |
| CMI | ▲ Buy | Grant | 12,675 | $0 | 3/1/2025 | View on chart |
| CMI | ▼ Sell | Open Market | 1 | $188 | 1/27/2025 | View on chart |
| CMI | ▲ Buy | Grant | 10,228 | $0 | 11/30/2024 | View on chart |
| CMI | ▲ Buy | Option Exercise | 7,070 | $771K | 5/17/2024 | View on chart |
| CMI | ▲ Buy | Option Exercise | 2,680 | $367K | 5/17/2024 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 261 | $0 | 5/17/2024 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 1,901 | $0 | 5/17/2024 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 4,630 | $0 | 5/17/2024 | View on chart |
| CMI | ▲ Buy | Option Exercise | 1,340 | $172K | 5/17/2024 | View on chart |
| CMI | ▲ Buy | Option Exercise | 350 | $54K | 5/17/2024 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 928 | $0 | 5/17/2024 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 4,277 | $1.2M | 3/1/2024 | View on chart |
| CMI | ▲ Buy | Grant | 10,785 | $0 | 3/1/2024 | View on chart |
| CMI | ▲ Buy | Option Exercise | 1,070 | $160K | 2/16/2024 | View on chart |
| CMI | ▼ Sell | Open Market | 739 | $197K | 2/16/2024 | View on chart |
| CMI | ▼ Sell | Open Market | 2 | $356 | 11/22/2023 | View on chart |
| CMI | ▲ Buy | Grant | 2,556 | $0 | 3/1/2023 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 748 | $186K | 3/1/2023 | View on chart |
| CMI | ▲ Buy | Option Exercise | 1,430 | $160K | 2/22/2023 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 871 | $218K | 2/22/2023 | View on chart |
| CMI | ▼ Sell | Gift | 1,882 | $0 | 5/5/2022 | View on chart |
| CMI | ▼ Sell | Gift | 1,882 | $0 | 5/5/2022 | View on chart |
| CMI | ▼ Sell | Gift | 170 | $0 | 5/4/2022 | View on chart |
| CMI | ▼ Sell | Gift | 170 | $0 | 5/4/2022 | View on chart |
| CMI | ▲ Buy | Option Exercise | 590 | $71K | 3/31/2022 | View on chart |
| CMI | ▼ Sell | Open Market | 420 | $88K | 3/31/2022 | View on chart |
| CMI | ▲ Buy | Grant | 243 | $0 | 3/1/2022 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 72 | $14K | 3/1/2022 | View on chart |
| CMI | ▼ Sell | Tax Withholding | 728 | $143K | 3/1/2022 | View on chart |
| CMI | ▲ Buy | Grant | 2,439 | $0 | 3/1/2022 | View on chart |
| CMI | ▼ Sell | Gift | 176 | $0 | 4/28/2021 | View on chart |
| CMI | ▼ Sell | Gift | 176 | $0 | 4/28/2021 | View on chart |
| CMI | ▼ Sell | Gift | 4,497 | $0 | 3/9/2021 | View on chart |
| CMI | ▼ Sell | Gift | 4,497 | $0 | 3/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings
3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings. 3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.